Literature DB >> 24368534

Serial changes of FDG uptake and diagnosis of suspected lung malignancy: a lesion-based analysis.

Gang Cheng1, Abass Alavi, Thomas J Werner, Catherine V Del Bello, Scott R Akers.   

Abstract

OBJECTIVE: This study prospectively evaluates the serial change of FDG uptake and its diagnostic value in malignant versus benign lung lesions in patients with suspected lung cancer. PATIENTS AND METHODS: Patients with suspected lung malignancy underwent whole-body FDG PET/CT at 1, 2, and 3 hours after an IV injection of F-FDG. The SUVs of FDG in lung nodules and hilar/mediastinal nodes at each time point were correlated with biopsy/surgical pathologic findings.
RESULTS: There were a total of 45 malignant lesions and 80 benign lesions from 43 patients with pathologic diagnosis that were included for analysis. The SUVmax had an average of 25.5% increase in all tumor-positive lesions from 1 to 2 hours (vs 1.6% decrease in all tumor-negative lesions, P < 0.0001) and an average of 39.1% increase from 1 to 3 hours (vs 4.5% increase in all tumor-negative lesions, P < 0.0001). The receiver operating characteristic analysis showed that the 2-hour and 3-hour SUVmax had similar area under the curve and outperformed the SUVmax on the 1-hour initial imaging or retention index (RI). The optimal cutoff values to differentiate malignancy from benign lesions were 3.24 for 1-hour SUVmax, 3.67 for 2-hour SUVmax, and 4.21 for 3-hour SUVmax, with 11.6% for 1- to 2-hour RI and 23.9% for 1- to 3-hour RI. The 3-hour delayed SUVmax of 4.21 provided the best overall performance (accuracy of 88.8%). The analysis of the lesion-to-background ratio revealed that delayed imaging improved the image quality significantly, leading to much easier detection of either malignant or benign lesions.
CONCLUSIONS: Multiple time point FDG PET/CT imaging moderately improves the diagnostic accuracy of lung cancer and significantly improves the image quality.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24368534     DOI: 10.1097/RLU.0000000000000313

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  5 in total

1.  Dual-Time-Point FDG PET/CT to Distinguish Coccidioidal Pulmonary Nodules from Those Due to Malignancy.

Authors:  Ahmed K Pasha; Travis K Walsh; Neil M Ampel
Journal:  Lung       Date:  2015-07-23       Impact factor: 2.584

2.  Intra-individual comparison of PET/CT with different body weight-adapted FDG dosage regimens.

Authors:  Jan H Geismar; Paul Stolzmann; Bert-Ram Sah; Irene A Burger; Burkhardt Seifert; Gaspar Delso; Gustav K von Schulthess; Patrick Veit-Haibach; Lars Husmann
Journal:  Acta Radiol Open       Date:  2015-01-29

3.  The value of diffusion kurtosis imaging, diffusion weighted imaging and 18F-FDG PET for differentiating benign and malignant solitary pulmonary lesions and predicting pathological grading.

Authors:  Ziqiang Li; Yu Luo; Han Jiang; Nan Meng; Zhun Huang; Pengyang Feng; Ting Fang; Fangfang Fu; Xiaochen Li; Yan Bai; Wei Wei; Yang Yang; Jianmin Yuan; Jianjian Cheng; Meiyun Wang
Journal:  Front Oncol       Date:  2022-07-29       Impact factor: 5.738

4.  Does Delayed-Time-Point Imaging Improve 18F-FDG-PET in Patients With MALT Lymphoma?: Observations in a Series of 13 Patients.

Authors:  Marius E Mayerhoefer; Chiara Giraudo; Daniela Senn; Markus Hartenbach; Michael Weber; Ivo Rausch; Barbara Kiesewetter; Christian J Herold; Marcus Hacker; Matthias Pones; Ingrid Simonitsch-Klupp; Leonhard Müllauer; Werner Dolak; Julius Lukas; Markus Raderer
Journal:  Clin Nucl Med       Date:  2016-02       Impact factor: 7.794

5.  Clinical significance of dual-time-point 18F-FDG PET imaging in resectable non-small cell lung cancer.

Authors:  Katsuhiko Shimizu; Riki Okita; Shinsuke Saisho; Takuro Yukawa; Ai Maeda; Yuji Nojima; Masao Nakata
Journal:  Ann Nucl Med       Date:  2015-08-08       Impact factor: 2.668

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.